A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Public ClinicalTrials.gov record NCT07441642. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double Masked, Placebo-controlled, Multicenter, Dose-range Finding Study to Assess the Efficacy and Safety of FWY003 in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To characterize the dose response relationship of FWY003 in participants with geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
Study identification
- NCT ID
- NCT07441642
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 272 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 8, 2026
- Primary completion
- Aug 20, 2029
- Completion
- Aug 21, 2029
- Last update posted
- Sep 8, 2026
2026 – 2029
United States locations
- U.S. sites
- 15
- U.S. states
- 7
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Salehi Retina Institute | Huntington Beach | California | 92647 | Recruiting |
| Retinal Consultants Medical Group Inc | Sacramento | California | 95841 | Recruiting |
| California Retina Consultants | Santa Barbara | California | 93103 | Recruiting |
| Advanced Research LLC | Boynton Beach | Florida | 33437 | Recruiting |
| Advanced Research LLC | Deerfield Beach | Florida | 33064 | Recruiting |
| Retina Vitreous Associates of Florida | St. Petersburg | Florida | 33711 | Recruiting |
| Opthamalic Consultants of Boston | Boston | Massachusetts | 02114 | Recruiting |
| NJ Retina | Toms River | New Jersey | 08755 | Recruiting |
| New York Eye and Ear Infirmary of Mount Sinai | New York | New York | 10003 | Recruiting |
| Columbia University Medical Center | New York | New York | 10032 | Recruiting |
| Erie Retina Research LLC | Erie | Pennsylvania | 16505 | Recruiting |
| Mid Atlantic Retina | Philadelphia | Pennsylvania | 19107 | Recruiting |
| Retina Consultants TX Rsrch Ctr | Bellaire | Texas | 77401 | Recruiting |
| Retina Consultants of Houston PA | Houston | Texas | 77030 | Recruiting |
| Retina Consultants of Texas | Katy | Texas | 77494 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 40 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07441642, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 8, 2026 · Synced Sep 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07441642 live on ClinicalTrials.gov.